Ultrashort Echo-Time MRI IDs Lung Abnormalities in CF

Share this content:
Ultrashort Echo-Time MRI IDs Lung Abnormalities in CF
Ultrashort Echo-Time MRI IDs Lung Abnormalities in CF

FRIDAY, Sept. 2, 2016 (HealthDay News) -- For children with cystic fibrosis (CF), ultrashort echo-time (UTE) magnetic resonance imaging (MRI) can detect structural lung disease, according to a study published online Aug. 23 in the Annals of the American Thoracic Society.

David J. Roach, Ph.D., from the Cincinnati Children's Hospital Medical Center, and colleagues compared UTE MRI methods with computed tomography (CT) as a biomarker of lung structure abnormalities. Eleven patients with CF underwent imaging via CT and UTE MRI. Eleven healthy age-matched patients underwent UTE MRI. CT scans from 13 additional patients were included as a CT control group.

The researchers observed very strong correlations between CT and UTE MRI scores of CF patients, with P values ≤0.001 for bronchiectasis and overall score; a moderately strong correlation was seen for bronchial wall thickening (P = 0.043). Using a reader CF-specific scoring system, MRI was able to differentiate CF from control groups.

"UTE MRI detected structural lung disease in very young CF patients and provided imaging data that correlated well with CT," the authors write. "By quantifying early CF lung disease without using ionizing radiation, UTE MRI appears well suited for pediatric patients requiring longitudinal imaging for clinical care or research studies."

Two authors disclosed financial ties to Vertex Pharmaceuticals, which funded the study.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Extended-Release Naltrexone Promising for Opioid Dependence

Extended-Release Naltrexone Promising for Opioid Dependence

Lower use of heroin, other illicit opioids with extended-release naltrexone in superiority analysis

New Expert Consensus Pathway for Mitral Regurgitation

New Expert Consensus Pathway for Mitral Regurgitation

Etiology, mechanism, severity, indications for treatment should be assessed after MR is identified

Many Dermatology Guideline Authors Get Industry Payments

Many Dermatology Guideline Authors Get Industry Payments

22 of 40 guideline authors receiving payments did not accurately disclose industry relationships

is free, fast, and customized just for you!

Already a member?

Sign In Now »